GC2302 Study Site 104

Asheville, North Carolina 28803

0 studies enrolling now · 1 studies all time

What they study most

Dry Eye Disease

Studies at this site

• Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED). — Completed